A recent US Food and Drug Administration (FDA) press release on the endocrine-disrupting chemical bisphenol A (BPA) was met with widespread criticism from scientists outside the agency.

The February statement from Stephen Ostroff, MD, the FDA deputy commissioner for foods and veterinary medicine, said a pre–peer review draft report of a 2-year study involving rats supported the agency’s prior determination that BPA is safe for currently authorized uses in food containers and packaging.